Inhixa enoxaparin regulatory update

EMA’s CHMP recommended approval of Inhixa enoxaparin from Techdow’s Techdow Europe AB unit to treat and prevent disorders related to blood clots in adults. Inhixa is a biosimilar of Lovenox, a low mo...